Logo image of GMVD

G MEDICAL INNOVATION HOLDING (GMVD) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:GMVD - KYG394621414 - Common Stock

0.181 USD
0 (0%)
Last: 8/23/2023, 8:23:00 PM
0.154 USD
-0.03 (-14.92%)
After Hours: 8/23/2023, 8:23:00 PM
Fundamental Rating

0

Taking everything into account, GMVD scores 0 out of 10 in our fundamental rating. GMVD was compared to 103 industry peers in the Health Care Providers & Services industry. GMVD may be in some trouble as it scores bad on both profitability and health. GMVD does not seem to be growing, but still is valued expensively.

Note: GMVD has only limited data available, so a full analysis was not possible, which makes the total rating unfair.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

GMVD Yearly Net Income VS EBIT VS OCF VS FCFGMVD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 -5M -10M -15M -20M -25M

1.2 Ratios

  • The profitability ratios for GMVD are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GMVD Yearly ROA, ROE, ROICGMVD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 0 500 -500 1K

1.3 Margins

  • GMVD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GMVD Yearly Profit, Operating, Gross MarginsGMVD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 0 -5K -10K -15K -20K

More info and screens

0

2. Health

2.1 Basic Checks

  • GMVD does not have a ROIC to compare to the WACC, probably because it is not profitable.
GMVD Yearly Shares OutstandingGMVD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 500K 1M 1.5M 2M
GMVD Yearly Total Debt VS Total AssetsGMVD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 5M 10M 15M 20M

2.2 Solvency

Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC3.39%
GMVD Yearly LT Debt VS Equity VS FCFGMVD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 0 5M -5M -10M -15M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
GMVD Yearly Current Assets VS Current LiabilitesGMVD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GMVD Yearly Revenue VS EstimatesGMVD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2023 2024 10M 20M 30M
GMVD Yearly EPS VS EstimatesGMVD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2023 2024 0 -10 -20 -30 -40

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
GMVD Price Earnings VS Forward Price EarningsGMVD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GMVD Per share dataGMVD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for GMVD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

G MEDICAL INNOVATION HOLDING / GMVD FAQ

Can you provide the ChartMill fundamental rating for G MEDICAL INNOVATION HOLDING?

ChartMill assigns a fundamental rating of 0 / 10 to GMVD.


What is the valuation status for GMVD stock?

ChartMill assigns a valuation rating of 0 / 10 to G MEDICAL INNOVATION HOLDING (GMVD). This can be considered as Overvalued.


What is the profitability of GMVD stock?

G MEDICAL INNOVATION HOLDING (GMVD) has a profitability rating of 0 / 10.


What is the financial health of G MEDICAL INNOVATION HOLDING (GMVD) stock?

The financial health rating of G MEDICAL INNOVATION HOLDING (GMVD) is 0 / 10.